These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 27666777)

  • 1. The heparanase/heparan sulfate proteoglycan axis: A potential new therapeutic target in sarcomas.
    Cassinelli G; Zaffaroni N; Lanzi C
    Cancer Lett; 2016 Nov; 382(2):245-254. PubMed ID: 27666777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparanase: A Potential Therapeutic Target in Sarcomas.
    Cassinelli G; Lanzi C
    Adv Exp Med Biol; 2020; 1221():405-431. PubMed ID: 32274719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug Resistance.
    Lanzi C; Zaffaroni N; Cassinelli G
    Curr Med Chem; 2017; 24(26):2860-2886. PubMed ID: 28215163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor tyrosine kinases and heparan sulfate proteoglycans: Interplay providing anticancer targeting strategies and new therapeutic opportunities.
    Lanzi C; Cassinelli G
    Biochem Pharmacol; 2020 Aug; 178():114084. PubMed ID: 32526230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of heparanase inhibitors in cancer therapy.
    Heyman B; Yang Y
    Exp Hematol; 2016 Nov; 44(11):1002-1012. PubMed ID: 27576132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparanase and cancer progression: New directions, new promises.
    Arvatz G; Weissmann M; Ilan N; Vlodavsky I
    Hum Vaccin Immunother; 2016 Sep; 12(9):2253-6. PubMed ID: 27054564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor efficacy of the heparan sulfate mimic roneparstat (SST0001) against sarcoma models involves multi-target inhibition of receptor tyrosine kinases.
    Cassinelli G; Favini E; Dal Bo L; Tortoreto M; De Maglie M; Dagrada G; Pilotti S; Zunino F; Zaffaroni N; Lanzi C
    Oncotarget; 2016 Jul; 7(30):47848-47863. PubMed ID: 27374103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparanase: Potential roles in multiple sclerosis.
    Changyaleket B; Deliu Z; Chignalia AZ; Feinstein DL
    J Neuroimmunol; 2017 Sep; 310():72-81. PubMed ID: 28778449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparanase: From basic research to therapeutic applications in cancer and inflammation.
    Vlodavsky I; Singh P; Boyango I; Gutter-Kapon L; Elkin M; Sanderson RD; Ilan N
    Drug Resist Updat; 2016 Nov; 29():54-75. PubMed ID: 27912844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor efficacy of the heparanase inhibitor SST0001 alone and in combination with antiangiogenic agents in the treatment of human pediatric sarcoma models.
    Cassinelli G; Lanzi C; Tortoreto M; Cominetti D; Petrangolini G; Favini E; Zaffaroni N; Pisano C; Penco S; Vlodavsky I; Zunino F
    Biochem Pharmacol; 2013 May; 85(10):1424-32. PubMed ID: 23466421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of endothelial proteoglycan and heparanase gene expression by high glucose, insulin and heparin.
    Han J; Hiebert LM
    Vascul Pharmacol; 2013; 59(3-4):112-8. PubMed ID: 23939434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperpigmentation in human solar lentigo is promoted by heparanase-induced loss of heparan sulfate chains at the dermal-epidermal junction.
    Iriyama S; Ono T; Aoki H; Amano S
    J Dermatol Sci; 2011 Dec; 64(3):223-8. PubMed ID: 22005029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies.
    Sanderson RD; Yang Y; Kelly T; MacLeod V; Dai Y; Theus A
    J Cell Biochem; 2005 Dec; 96(5):897-905. PubMed ID: 16149080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of heparanase in migration of microglial cells.
    Takahashi H; Matsumoto H; Smirkin A; Itai T; Nishimura Y; Tanaka J
    Biochim Biophys Acta; 2008 Apr; 1780(4):709-15. PubMed ID: 18222122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-clinical and clinical significance of heparanase in Ewing's sarcoma.
    Shafat I; Ben-Arush MW; Issakov J; Meller I; Naroditsky I; Tortoreto M; Cassinelli G; Lanzi C; Pisano C; Ilan N; Vlodavsky I; Zunino F
    J Cell Mol Med; 2011 Sep; 15(9):1857-64. PubMed ID: 21029368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Good and Bad Sides of Heparanase-1 and Heparanase-2.
    Pinhal MAS; Melo CM; Nader HB
    Adv Exp Med Biol; 2020; 1221():821-845. PubMed ID: 32274740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development.
    Vlodavsky I; Goldshmidt O; Zcharia E; Atzmon R; Rangini-Guatta Z; Elkin M; Peretz T; Friedmann Y
    Semin Cancer Biol; 2002 Apr; 12(2):121-9. PubMed ID: 12027584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy.
    Sanderson RD; Elkin M; Rapraeger AC; Ilan N; Vlodavsky I
    FEBS J; 2017 Jan; 284(1):42-55. PubMed ID: 27758044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
    Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparanase - Discovery and Targets.
    Lindahl U; Li JP
    Adv Exp Med Biol; 2020; 1221():61-69. PubMed ID: 32274706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.